Skip to main content
PMC home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1996 Sep;29:S54–S60.

Cancer clinical outcomes for minority ethnic groups.

P Selby 1
PMCID: PMC2149868  PMID: 8782801

Full text

PDF
S58

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson N. K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N. J., Filiberti A., Flechtner H., Fleishman S. B., de Haes J. C. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365–376. doi: 10.1093/jnci/85.5.365. [DOI] [PubMed] [Google Scholar]
  2. Austin J. P., Aziz H., Potters L., Thelmo W., Chen P., Choi K., Brandys M., Macchia R. J., Rotman M. Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol. 1990 Dec;13(6):465–469. doi: 10.1097/00000421-199012000-00002. [DOI] [PubMed] [Google Scholar]
  3. Axtell L. M., Myers M. H. Contrasts in survival of black and white cancer patients, 1960-73. J Natl Cancer Inst. 1978 Jun;60(6):1209–1215. doi: 10.1093/jnci/60.6.1209. [DOI] [PubMed] [Google Scholar]
  4. Burbank F., Fraumeni J. F., Jr U.S. cancer mortality: nonwhite predominance. J Natl Cancer Inst. 1972 Sep;49(3):649–659. [PubMed] [Google Scholar]
  5. Christopherson W. M., Nealon N. A. Uterine cancer: a comparative study of black and white women. Prog Clin Biol Res. 1981;53:185–195. [PubMed] [Google Scholar]
  6. Coates A., Gebski V., Bishop J. F., Jeal P. N., Woods R. L., Snyder R., Tattersall M. H., Byrne M., Harvey V., Gill G. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med. 1987 Dec 10;317(24):1490–1495. doi: 10.1056/NEJM198712103172402. [DOI] [PubMed] [Google Scholar]
  7. Coates R. J., Bransfield D. D., Wesley M., Hankey B., Eley J. W., Greenberg R. S., Flanders D., Hunter C. P., Edwards B. K., Forman M. Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1992 Jun 17;84(12):938–950. doi: 10.1093/jnci/84.12.938. [DOI] [PubMed] [Google Scholar]
  8. Coates R. J., Greenberg R. S., Liu M. T., Correa P., Harlan L. C., Reynolds P., Fenoglio-Preiser C. M., Haynes M. A., Hankey B. F., Hunter C. P. Anatomic site distribution of colon cancer by race and other colon cancer risk factors. Dis Colon Rectum. 1995 Jan;38(1):42–50. doi: 10.1007/BF02053856. [DOI] [PubMed] [Google Scholar]
  9. Deyo R. A., Patrick D. L. Barriers to the use of health status measures in clinical investigation, patient care, and policy research. Med Care. 1989 Mar;27(3 Suppl):S254–S268. doi: 10.1097/00005650-198903001-00020. [DOI] [PubMed] [Google Scholar]
  10. Finkelstein D. M., Cassileth B. R., Bonomi P. D., Ruckdeschel J. C., Ezdinli E. Z., Wolter J. M. A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1988 Dec;11(6):630–633. doi: 10.1097/00000421-198812000-00007. [DOI] [PubMed] [Google Scholar]
  11. Ganz P. A., Lee J. J., Siau J. Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer. 1991 Jun 15;67(12):3131–3135. doi: 10.1002/1097-0142(19910615)67:12<3131::aid-cncr2820671232>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  12. Geddes D. M., Dones L., Hill E., Law K., Harper P. G., Spiro S. G., Tobias J. S., Souhami R. L. Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. Eur J Cancer. 1990 Apr;26(4):484–492. doi: 10.1016/0277-5379(90)90022-l. [DOI] [PubMed] [Google Scholar]
  13. Gelber R. D., Goldhirsch A. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol. 1986 Dec;4(12):1772–1779. doi: 10.1200/JCO.1986.4.12.1772. [DOI] [PubMed] [Google Scholar]
  14. Goldhirsch A., Gelber R. D., Simes R. J., Glasziou P., Coates A. S. Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. J Clin Oncol. 1989 Jan;7(1):36–44. doi: 10.1200/JCO.1989.7.1.36. [DOI] [PubMed] [Google Scholar]
  15. Hayes R. B., Liff J. M., Pottern L. M., Greenberg R. S., Schoenberg J. B., Schwartz A. G., Swanson G. M., Silverman D. T., Brown L. M., Hoover R. N. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer. 1995 Jan 27;60(3):361–364. doi: 10.1002/ijc.2910600315. [DOI] [PubMed] [Google Scholar]
  16. Howard J., Hankey B. F., Greenberg R. S., Austin D. F., Correa P., Chen V. W., Durako S. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer. 1992 May 1;69(9):2349–2360. doi: 10.1002/1097-0142(19920501)69:9<2349::aid-cncr2820690925>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  17. Hunter C. P., Redmond C. K., Chen V. W., Austin D. F., Greenberg R. S., Correa P., Muss H. B., Forman M. R., Wesley M. N., Blacklow R. S. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1993 Jul 21;85(14):1129–1137. doi: 10.1093/jnci/85.14.1129. [DOI] [PubMed] [Google Scholar]
  18. Irvine D., Brown B., Crooks D., Roberts J., Browne G. Psychosocial adjustment in women with breast cancer. Cancer. 1991 Feb 15;67(4):1097–1117. doi: 10.1002/1097-0142(19910215)67:4<1097::aid-cncr2820670438>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  19. Jensen O. M., Estève J., Møller H., Renard H. Cancer in the European Community and its member states. Eur J Cancer. 1990;26(11-12):1167–1256. doi: 10.1016/0277-5379(90)90278-2. [DOI] [PubMed] [Google Scholar]
  20. Johnson J. R., Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep. 1985 Oct;69(10):1155–1159. [PubMed] [Google Scholar]
  21. Kiebert G. M., de Haes J. C., van de Velde C. J. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol. 1991 Jun;9(6):1059–1070. doi: 10.1200/JCO.1991.9.6.1059. [DOI] [PubMed] [Google Scholar]
  22. Kovi J., Viola M. V., Connolly C. A., Vohra R. Gastric cancer in American negroes. Cancer. 1974 Sep;34(3):765–770. doi: 10.1002/1097-0142(197409)34:3<765::aid-cncr2820340336>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  23. Levine R. L., Wilchinsky M. Adenocarcinoma of the prostate: a comparison of the disease in blacks versus whites. J Urol. 1979 Jun;121(6):761–762. doi: 10.1016/s0022-5347(17)56981-5. [DOI] [PubMed] [Google Scholar]
  24. Maguire P., Selby P. Assessing quality of life in cancer patients. Br J Cancer. 1989 Sep;60(3):437–440. doi: 10.1038/bjc.1989.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mayberry R. M., Coates R. J., Hill H. A., Click L. A., Chen V. W., Austin D. F., Redmond C. K., Fenoglio-Preiser C. M., Hunter C. P., Haynes M. A. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995 Nov 15;87(22):1686–1693. doi: 10.1093/jnci/87.22.1686. [DOI] [PubMed] [Google Scholar]
  26. Mettlin C., Natarajan N., Mittelman A., Smart C. R., Murphy G. P. Management and survival of adenocarcinoma of the rectum in the United States: results of a national survey by the American College of Surgeons. Oncology. 1982;39(5):265–273. doi: 10.1159/000225649. [DOI] [PubMed] [Google Scholar]
  27. Mettlin C., Natarajan N., Murphy G. P. Recent patterns of care of prostate cancer patients in the United States: results from the surveys of the American college of Surgeons Commission on Cancer. Int Adv Surg Oncol. 1982;5:277–321. [PubMed] [Google Scholar]
  28. Moinpour C. M., Feigl P., Metch B., Hayden K. A., Meyskens F. L., Jr, Crowley J. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst. 1989 Apr 5;81(7):485–495. doi: 10.1093/jnci/81.7.485. [DOI] [PubMed] [Google Scholar]
  29. Muir C. S., Nectoux J., Staszewski J. The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol. 1991;30(2):133–140. doi: 10.3109/02841869109092336. [DOI] [PubMed] [Google Scholar]
  30. Murphy G. P., Natarajan N., Pontes J. E., Schmitz R. L., Smart C. R., Schmidt J. D., Mettlin C. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol. 1982 May;127(5):928–934. doi: 10.1016/s0022-5347(17)54135-x. [DOI] [PubMed] [Google Scholar]
  31. Muss H. B., Hunter C. P., Wesley M., Correa P., Chen V. W., Greenberg R. S., Eley J. W., Austin D. F., Kurman R., Edwards B. K. Treatment plans for black and white women with stage II node-positive breast cancer. The National Cancer Institute Black/White Cancer Survival Study experience. Cancer. 1992 Nov 15;70(10):2460–2467. doi: 10.1002/1097-0142(19921115)70:10<2460::aid-cncr2820701012>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  32. Nemoto T., Vana J., Natarajan N., Bedwani R., Mettlin C. Observations on short-term and long-term surveys of breast cancer by the American College of Surgeons. I. Significance of the number of axillary nodes and II. Estrogen receptor assay in the U.S. in 1977. Int Adv Surg Oncol. 1981;4:209–239. [PubMed] [Google Scholar]
  33. O'Young J., McPeek B. Quality of life variables in surgical trials. J Chronic Dis. 1987;40(6):513–522. doi: 10.1016/0021-9681(87)90008-7. [DOI] [PubMed] [Google Scholar]
  34. Polednak A. P. Breast cancer in black and white women in New York State. Case distribution and incidence rates by clinical stage at diagnosis. Cancer. 1986 Aug 1;58(3):807–815. doi: 10.1002/1097-0142(19860801)58:3<807::aid-cncr2820580333>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  35. Polednak A. P., Flannery J. T. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer. 1992 Oct 15;70(8):2152–2158. doi: 10.1002/1097-0142(19921015)70:8<2152::aid-cncr2820700824>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  36. Priestman T. J., Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet. 1976 Apr 24;1(7965):899–900. doi: 10.1016/s0140-6736(76)92112-7. [DOI] [PubMed] [Google Scholar]
  37. Reynolds P., Boyd P. T., Blacklow R. S., Jackson J. S., Greenberg R. S., Austin D. F., Chen V. W., Edwards B. K. The relationship between social ties and survival among black and white breast cancer patients. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):253–259. [PubMed] [Google Scholar]
  38. Ries L. G., Pollack E. S., Young J. L., Jr Cancer patient survival: Surveillance, Epidemiology, and End Results Program, 1973-79. J Natl Cancer Inst. 1983 Apr;70(4):693–707. [PubMed] [Google Scholar]
  39. Ross R. K., Shimizu H., Paganini-Hill A., Honda G., Henderson B. E. Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst. 1987 May;78(5):869–874. [PubMed] [Google Scholar]
  40. Ross R., Bernstein L., Judd H., Hanisch R., Pike M., Henderson B. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst. 1986 Jan;76(1):45–48. [PubMed] [Google Scholar]
  41. Schipper H., Clinch J., McMurray A., Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol. 1984 May;2(5):472–483. doi: 10.1200/JCO.1984.2.5.472. [DOI] [PubMed] [Google Scholar]
  42. Shapiro S., Venet W., Strax P., Venet L., Roeser R. Prospects for eliminating racial differences in breast cancer survival rates. Am J Public Health. 1982 Oct;72(10):1142–1145. doi: 10.2105/ajph.72.10.1142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sprangers M. A., Cull A., Bjordal K., Groenvold M., Aaronson N. K. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res. 1993 Aug;2(4):287–295. doi: 10.1007/BF00434800. [DOI] [PubMed] [Google Scholar]
  44. Steinhorn S. C., Myers M. H., Hankey B. F., Pelham V. F. Factors associated with survival differences between black women and white women with cancer of the uterine corpus. Am J Epidemiol. 1986 Jul;124(1):85–93. doi: 10.1093/oxfordjournals.aje.a114373. [DOI] [PubMed] [Google Scholar]
  45. Sugarbaker P. H., Barofsky I., Rosenberg S. A., Gianola F. J. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery. 1982 Jan;91(1):17–23. [PubMed] [Google Scholar]
  46. Veldhuyzen Van Zanten S. J. Quality of life as outcome measures in randomized clinical trials. An overview of three general medical journals. Control Clin Trials. 1991 Aug;12(4 Suppl):234S–242S. doi: 10.1016/s0197-2456(05)80027-3. [DOI] [PubMed] [Google Scholar]
  47. Young J. L., Jr, Ries L. G., Pollack E. S. Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst. 1984 Aug;73(2):341–352. doi: 10.1093/jnci/73.2.341. [DOI] [PubMed] [Google Scholar]
  48. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  49. de Haes J. C., van Knippenberg F. C., Neijt J. P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990 Dec;62(6):1034–1038. doi: 10.1038/bjc.1990.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. van Holten-Verzantvoort A. T., Zwinderman A. H., Aaronson N. K., Hermans J., van Emmerik B., van Dam F. S., van den Bos B., Bijvoet O. L., Cleton F. J. The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. Eur J Cancer. 1991;27(5):544–549. doi: 10.1016/0277-5379(91)90212-v. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES